|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn960282698 |
003 |
OCoLC |
005 |
20231120112143.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
161011s2017 enk ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d N$T
|d IDEBK
|d EBLCP
|d N$T
|d OPELS
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCO
|d MERUC
|d OCLCQ
|d OTZ
|d VGM
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d U3W
|d OCLCO
|d OCLCQ
|d GILDS
|d D6H
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d LQU
|d OCLCQ
|d LVT
|d OCLCO
|d OCL
|d OCLCQ
|
019 |
|
|
|a 960493466
|a 964931305
|a 1066447437
|a 1105180306
|a 1105574802
|a 1162388972
|a 1229812638
|
020 |
|
|
|a 9780128046203
|q (electronic bk.)
|
020 |
|
|
|a 0128046201
|q (electronic bk.)
|
020 |
|
|
|z 9780128045985
|
020 |
|
|
|z 0128045981
|
035 |
|
|
|a (OCoLC)960282698
|z (OCoLC)960493466
|z (OCoLC)964931305
|z (OCoLC)1066447437
|z (OCoLC)1105180306
|z (OCoLC)1105574802
|z (OCoLC)1162388972
|z (OCoLC)1229812638
|
050 |
|
4 |
|a R857.N34
|
060 |
|
4 |
|a QT 36.5
|
072 |
|
7 |
|a MED
|x 096000
|2 bisacsh
|
072 |
|
7 |
|a TEC
|x 027000
|2 bisacsh
|
072 |
|
7 |
|a TEC
|x 059000
|2 bisacsh
|
082 |
0 |
4 |
|a 610.28
|2 23
|
245 |
0 |
0 |
|a Neurotoxicity of nanomaterials and nanomedicine /
|c edited by Xinguo Jiang, Huile Gao.
|
260 |
|
|
|a London :
|b Academic Press,
|c 2017.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource, title from PDF title page (EBSCO, viewed October 17, 2016).
|
520 |
|
|
|a Neurotoxicity of Nanomaterials and Nanomedicine presents an overview of the exciting research in neurotoxicity and nanomaterials. Nanomaterials have been extensively used in medicine, including diagnosis probes, drug carriers, and embedded materials. While some have been approved for clinical use, most nanomaterials are waiting to be transferred from lab to clinic. However, the toxicity is a main barrier that restricts the translation. This comprehensive book includes chapters on the most commonly used individual nanoparticles, with information on the applications, neurotoxicity, and related mechanisms of each, providing the most in-depth and current information available. The book examines the pathways that nanomaterials enter into, and eliminate, from the brain, along with the strategies that could reduce the neurotoxicity of nanomaterials. Providing a background to the subject, detailed information, and ideas for future directions in research, the book is essential for students and researchers in toxicology, and for those in medicine, neurology, pharmacology, pharmaceutical science, and materials science who are researching nanomaterials.
|
505 |
0 |
|
|a 1. The medical applications of nanomaterials in the central nervous system -- 2. The route of nanomaterials entering brain -- 3. The distribution and elimination of nanomaterials in brain -- 4. Current perspective on nanomaterial-induced adverse effects: neurotoxicity as a case example -- 5. Toxicity of titanium dioxide nanoparticles on brain -- 6. The application, neurotoxicity and related mechanism of iron oxide nanoparticles -- 7. The application, neurotoxicity and related mechanism of silver nanoparticles -- 8. The application, neurotoxicity and related mechanism of gold nanoparticles -- 9. The applications, neurotoxicity, and related mechanisms of managanese containing nanoparticles -- 10. The application, neurotoxicity and related mechanism of silica nanoparticles -- 11. The application, neurotoxicity and related mechanism of carbon nanotubes -- 12. The application, neurotoxicity and related mechanism of cationic polymers -- 13. to reduce neurotoxicity of nanomaterials and the corresponding mechanism.
|
650 |
|
0 |
|a Nanomedicine.
|
650 |
|
0 |
|a Nanostructured materials.
|
650 |
|
0 |
|a Neurotoxicology.
|
650 |
|
0 |
|a Nanotechnology.
|
650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
650 |
|
2 |
|a Nanostructures
|0 (DNLM)D049329
|
650 |
|
6 |
|a Nanomat�eriaux.
|0 (CaQQLa)201-0258061
|
650 |
|
6 |
|a Neurotoxicologie.
|0 (CaQQLa)201-0041644
|
650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
650 |
|
7 |
|a MEDICAL
|x Toxicology.
|2 bisacsh
|
650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Nanotechnology & MEMS.
|2 bisacsh
|
650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Biomedical.
|2 bisacsh
|
650 |
|
7 |
|a Nanotechnology.
|2 fast
|0 (OCoLC)fst01032639
|
650 |
|
7 |
|a Nanomedicine.
|2 fast
|0 (OCoLC)fst01744350
|
650 |
|
7 |
|a Nanostructured materials.
|2 fast
|0 (OCoLC)fst01032630
|
650 |
|
7 |
|a Neurotoxicology.
|2 fast
|0 (OCoLC)fst01036560
|
700 |
1 |
|
|a Jiang, Xinguo,
|e editor.
|
700 |
1 |
|
|a Gao, Huile,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Neurotoxicity of nanomaterials and nanomedicine.
|d London : Academic Press, 2017
|z 9780128045985
|z 0128045981
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128045985
|z Texto completo
|